RP 59500 prophylaxis of experimental endocarditis due to erythromycin-susceptible and -resistant isogenic pairs of viridans group streptococci.

RP 59500 is a new injectable streptogramin composed of two synergistic components (quinupristin and dalfopristin) which are active against a number of erythromycin-susceptible and -resistant gram-positive bacteria. The following experiments investigate the ability of RP 59500 to prevent experimental...

Full description

Bibliographic Details

Published in:	Antimicrob Agents Chemother
Main Authors:	L'Hériteau, F, Entenza, J M, Lacassin, F, Leport, C, Glauser, M P, Moreillon, P
Format:	Artigo
Language:	Inglês
Published:	American Society for Microbiology (ASM) 1995
Subjects:	Research Article
Online Access:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC162756/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7492079/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.39.7.1425
Tags:	Add Tag No Tags, Be the first to tag this record!